Skip to content
Search

Latest Stories

What will it take to get help from government? ask pharmacists

What will it take to get help from the government before an individual or sector breaks? Pharmacists raised questions after the Pharmaceutical Services Negotiating Committee (PSNC)’s 2023 Pharmacy Pressures Survey confirmed the ongoing pressures and health issues faced by the pharmacies.

Pharmacists are not all shocked by the PSNC’s survey report as they feel the same as what has been reported related to their businesses and health. They hope the government listens and work with them to find resolutions.


“We are bullied into a corner,” said Salim Jetha Chairman, Avicenna.

“Unlike other industries, we can’t increase our prices. Most of the daily calls I get from Independents is about financial health of their business and any cost cutting would be detrimental to patient care. Urgent holistic review is required.”

Bristol pharmacist Ade Williams said: “The report is a dire indictment, and I would also warn, likely an underestimate of the extent and detrimental impact of the ongoings pressures and squeeze on Community pharmacies.”

“If the closest interface of the NHS to communities and patients is so distressed, what does that mean for those that need and depend on us? We are notoriously very stoic, so this is a warning light, which, taken with workforce pressures, market-exit activity, and other reports raising concern about wellbeing and stress, must beg the question; what will it take to get help before the sector and individuals break?” he questioned.

The survey results don’t surprise Kent-based community pharmacist Amish Patel. He said, “I have been feeling exactly what has been reported for far too long. I’m burnt out and would say beginning to suffer with my own health because of it. Now it’s for PSNC to talk to government, and government to listen and work with us to find resolutions.”

Shedding some light on what pharmacists expect from the government, Olivier Picard owner of Newdays Pharmacy said: “The government will need to do several things. The first one is they need to address the existing funding of community pharmacy immediately so that the hundreds of pharmacies closures that we've seen in the last few years, don't run into the 1000s. Because that puts extra pressure on the neighbouring pharmacies. And we need this investment in the sector to be now, not in a year's time or two years time when a new contract is negotiated.

“The second thing that we need is extra funding for community pharmacy for new services. So any new services that is launched in community pharmacy. If we expect the pharmacist to do more, for the same amount of money, then I'm afraid we are setting ourselves to fail.”

“We need the government to think long and hard about the future of community pharmacy. Do they want a reduced network of pharmacies to just dish out pills from mail order? Or do they want a pharmacy network that is supporting their community supporting doctors, nurses, any department but taking the pressure of those other services so that everyone can work together. And the only way we're going to have this is if the government is reasonable about the next contract that is negotiated and issued and whether there is inflationary rise built up in that contract, whether there is extra services that are worth the pharmacy doing in that next contract.”

Government must adequately fund the pharmacies

The National Pharmacy Association (NPA) vice chair Nick Kaye commented: “This data is further confirmation that cuts have consequences, not only for pharmacy contractors and staff but also for patients. It’s tragic that pharmacists are now less able to provide the prompt service people have become used to over the years. It should also ring alarm bells in government and at NHS England that pharmacists are spending less time with each individual patient, as a result of funding cuts. Doing more and more for less and less is clearly unsustainable, as these results clearly show.”

The survey reflects the results of RPS Workforce Wellbeing survey which demonstrated that 70% of respondents identified inadequate staffing as one of the major issues affecting mental health and wellbeing in the workplace, and 88% rated as being at high risk of burnout.

The Royal Pharmaceutical Society (RPS) Director for England James Davies said: “We know pharmacists and their teams are experiencing burnout due to workforce and workload pressures, exacerbated by perpetual underfunding of the system.

“We hope that the upcoming NHS England workforce plan addresses some of the issues around retention and recruitment into the pharmacy workforce to help ease some of these pressures.

“Patients may need to wait a longer than usual due to increased pressures on the service. We ask patients to respect our pharmacy colleagues who are working incredibly hard to support patients with the advice and medicines they need.”

Dr Leyla Hannbeck CEO of AIMp said: “The government’s machinery are turning a blind eye to the plight of our sector and its impact on patient care and health inequalities. One example of serious pressures reported is the medicines supply issues.”

“For months AIM has been raising concerns about medicines supply challenges to DHSC, Ministers and in the national media — the DHSC have consistently denied that there are issues and they have failed to take action. Every year pharmacies fill in the pressure survey in the hope that their plight is heard and that decision makers take action. Our sector is currently fighting for its survival and we hope PSNC can use this data to effectively negotiate with the DHSC.”

“Patients need all of the health service, including community pharmacies, to be properly resourced and the PDA support pharmacy businesses in their efforts to secure fair funding for England’s pharmacies from the Westminster government,” said Paul Day Director, Pharmacists Defence Association (PDA) Union.

This is a serious concern and regardless of their own funding challenges employers must still meet their duty to ensuring the health and safety of those that they employ.

Such poor working conditions are also a contributor to many pharmacists reducing their hours, becoming locums or leaving practise altogether, which only adds to the pressures on community pharmacy operators and has other longer term impacts for the profession.

If England is to have the pharmacist workforce necessary to care for patients, employers must make their working environments safe for staff, as well as for patients, and government must adequately fund the pharmacy contract.”

A CCA spokesperson said: “The results of PSNC’s Pharmacy Pressures Survey come as no surprise. This is further confirmation that the pharmacy sector is on the brink of collapse. It is a sad reality that 81% of pharmacy owners are experiencing workload pressures, which is affecting their ability to help patients.

Earlier this year, the CCA uncovered that since 2015, there has been a net loss of 720 pharmacies – a worsening trend that shows no sign of abating. Coupled with underfunding of more than £67,000 per pharmacy annually, it is clear that the sector is fighting to survive.

It would be wholly irresponsible for Government to disregard the Pressures Survey’s findings. Community pharmacy funding is broken and needs a complete re-think – otherwise, we will continue to see a deterioration of the network, impacting patient care across the country particularly in the most deprived communities.

One step the Government must take is to commission a fully-funded Pharmacy First service in England. Recognising and rewarding the work coming into pharmacy from stretched GP services, is a crucial step in stabilising the network. This service would utilise the potential of community pharmacy to make a huge impact on patient access in primary care at a critical time for the NHS. We call on the NHS to use the upcoming Primary Care Recovery Plan to announce such a service.”

The survey of over 6,200 pharmacy premises and 2,000 pharmacy team members indicated that the majority (96%) of pharmacy owners are facing significantly higher costs than last year – up from 80% in the 2022 pressures survey – and many are operating understaffed due to both insufficient funding (48%) and staff unavailability (34%). But at the same time, 92% of pharmacy teams cited a significant increase in requests from patients unable to access General Practice and 71% reported problems sourcing medicines.

Many pharmacy staff (81%) say they are struggling to cope due to a significant rise in workload and 78% report that their work is having a negative impact on their mental health and wellbeing. And, unsurprisingly, 78% of pharmacy owners are extremely concerned about their business finances with 41% now extremely worried about their ability to help patients.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less